Many experts now predict that COVID-19, which so far has killed more than 5.5 million people worldwide, will remain endemic as new, infectious variants of SARS-CoV-2 emerge. These new variants could pose a greater risk of reinfection — infecting people who have already had COVID19 — than previous ones. The rapid identification of reinfection cases and surges could improve public health responses and reveal variants that escape the protection offered by vaccination.
Related Posts
Multi-Omics Characterization of Uveal Melanoma Reveals New Insights
Uveal melanoma (UM), a rare cancer originating from uveal tract melanocytes, exhibits four distinct molecular subsets. We conducted comprehensive multi-omics analysis comparing aggressive UM patient-derived xenograft models with normal melanocytes. Our findings highlight genomic instability as a UM hallmark. A recurrent BAP1 promoter deletion, linked to metastasis risk, was identified. Hi-C analysis unveiled chromatin topology […]
Black phosphorus: A new weapon in the fight against antibiotic-resistant infections
The material, called black phosphorus, is effective against a wide range of drug-resistant bacteria, including golden staph. In a recent study, black phosphorus was shown to kill over 99% of bacteria in biological models, without damaging other cells. Black phosphorus works by generating reactive oxygen species (ROS), which are highly toxic to bacteria. ROS damages […]
Cancer immunotherapy’s immune activation may cause colitis—research aims for solutions.
Researchers have identified that cancer immunotherapy can lead to colitis due to the activation of the immune system. Certain immunotherapies, such as immune checkpoint inhibitors, boost the immune response against cancer cells but may also inadvertently target healthy cells, including those in the colon. This immune system activation can cause inflammation in the colon, resulting […]